----
Current ValuationThe current P/E ratio is 24.71, within the reasonable range, cheaper than 31.31% of the time in the past 5 years, and the industry ranks 13/74, the industry Median --.
24.71xP/E
$94.48Stock price
$3.82Earnings per share
24.71xP/E
Stock price$94.48Earnings per share$3.82
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 17.57x
- Typical range
- 11.77x–36.03x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
07142128
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
CVSUSCVS Health | 24.71x | 394.45% | $120.84B |
DGXUSQuest Diagnostics | 23.87x | 17.76% | $26.85B |
LHUSLabcorp | 26.70x | 33.20% | $26.76B |
BTSGUSBrightSpring Health Services | 32.90x | 86.70% | $12.04B |
CHEUSChemed | 27.64x | 26.94% | $7.60B |
OPCHUSOption Care Health | 22.36x | 18.20% | $4.69B |
CRVLUSCorVel | 36.74x | -- | $4.24B |
GRDNUSGuardian Pharmacy Services | 38.05x | 56.67% | $2.51B |
ADUSUSAddus Homecare | 21.75x | 18.27% | $2.29B |
VMDUSViemed Healthcare | 26.06x | 11.71% | $377.84M |
INFUUSInfusystem | 32.97x | 37.64% | $281.63M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
